Papers
2
Total Citations
26
H-Index
2
About
Dr. Liyan Ao is a pioneering urologic surgeon and researcher whose work is redefining the boundaries of prostate and kidney cancer treatment. His primary research areas include precision oncology, advanced imaging integration, and minimally invasive robotic surgery. Dr. Ao’s most groundbreaking contribution is his 2024 prospective trial, which challenges the diagnostic status quo by demonstrating the feasibility of performing radical prostatectomy without a prior biopsy in highly selected patients, using a novel combination of 18F-labeled PSMA PET/CT and multiparameter MRI. This landmark study, already garnering 19 citations, has the potential to streamline care and reduce patient morbidity. In the realm of renal surgery, Dr. Ao has made a significant impact with a large retrospective cohort study of 1,040 patients. This work provides critical evidence that the retroperitoneal robotic approach is suitable for renal tumors in all locations, a finding that has earned 7 citations and is guiding surgical decision-making. Through these contributions, Dr. Ao is advancing the frontiers of urologic oncology, offering patients more precise, less invasive, and potentially life-changing treatment pathways.
Research Focus
Key Achievements
Top Papers
- 1
- 2